Sanofi Other Non-Current Liabilities 2012-2026 | SNY

Sanofi other non-current liabilities for the quarter ending March 31, 2026 were $11.017B, a 6.95% increase year-over-year.

  • Sanofi other non-current liabilities for 2024 were $11.013B, a 2.31% increase from 2023.
  • Sanofi other non-current liabilities for 2023 were $10.763B, a 13.59% increase from 2022.
  • Sanofi other non-current liabilities for 2022 were $9.476B, a 14.22% decline from 2021.

Sanofi Other Non-Current Liabilities 2012-2026 | SNY

  • Sanofi other non-current liabilities for 2024 were $11.013B, a 2.31% increase from 2023.
  • Sanofi other non-current liabilities for 2023 were $10.763B, a 13.59% increase from 2022.
  • Sanofi other non-current liabilities for 2022 were $9.476B, a 14.22% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B